Approximately 70 to 300 million individuals worldwide are living with myasthenia gravis, an antibody-mediated autoimmune disorder that adversely affects neuromuscular junction function.
### Key messages
> New immunomodulatory therapeutics hold promise for the future treatment of myasthenia gravis, say DeHart-McCoyle and colleagues
Myasthenia gravis is an antibody mediated autoimmune disorder affecting the function of the neuromuscular junction, leading to fluctuating weakness of
Want To Make Your Mind More Skillful And Crush Your Goals? Of Course, You Do: Learn These 4 Rare Psychological Skills Only True Masters Of The Universe Know.